Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
株式のランク #38665
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
株価
$0.04057595
最終同期: 2024-08-05
時価総額
$863.62K
変化(1日)
0.31%
変化(1年)
0.00%
SE
取引 AegirBio AB (publ) (AEGIR)

カテゴリー

AegirBio AB (publ)(AEGIR)のEPS
September 2024 時点のEPS TTM: $-0.11
AegirBio AB (publ)の最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-0.11です。2022年末には、EPSは$-1.81で、2021年のEPS$-0.62と増加でした。
AegirBio AB (publ)のEPS履歴(2019から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-0.11 -52.38%
2023 $-0.24 -86.98%
2022 $-1.81 190.84%
2021 $-0.62 478.64%
2020 $-0.11 0.00%
2019 0.00 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$8.85 -7,842.78%
US
$6.41 -5,703.85%
FR
- -
JP
$3.32 -3,004.64%
US
- -
CH